Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. ECCO topical review: Refractory Inflammatory Bowel Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Bariatric surgery and risk of new-onset inflammatory bowel disease: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The burden of inflammatory bowel disease in Europe in 2020

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. A reliability study - strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  • Johan F K F Ilvemark
  • Tawnya Hansen
  • Thomas M Goodsall
  • Jakob B Seidelin
  • Heba Al-Farhan
  • Mariangela Allocca
  • Jakob Begun
  • Robert V Bryant
  • Dan Carter
  • Britt Christensen
  • Marla C Dubinsky
  • Krisztina B Gecse
  • Torsten Kucharzik
  • Cathy Lu
  • Christian Maaser
  • Giovanni Maconi
  • Kim Nylund
  • Carolina Palmela
  • Stephanie R Wilson
  • Kerri Novak
  • Rune Wilkens
Vis graf over relationer

BACKGROUND AND AIMS: No consensus exists on defining intestinal ultrasound response, transmural healing, or transmural remission in inflammatory bowel disease, nor clear guidance for optimal timing of assessment during treatment. This systematic review and expert consensus study aimed to define such recommendations, along with key parameters included in response reporting.

METHODS: Electronic databases were searched from inception to July 26, 2021, using pre-defined terms. Studies were eligible if at least two intestinal ultrasound assessments at different time points during treatment were reported, along with an appropriate reference standard. The QUADAS-2 tool was used to examine study-level risk of bias. An international panel of experts (n=18) rated an initial 196 statements (RAND/UCLA process, scale 1-9). Two videoconferences were conducted, resulting in additional ratings of 149 and 13 statements, respectively.

RESULTS: Out of 5826 records, 31 full-text articles, 16 abstracts, and one research letter were included. 83% (40/48) of included studies showed a low concern of applicability, while 96% (46/48) had a high risk of bias. A consensus was reached on 41 statements, with clear definitions of IUS treatment response, transmural healing, transmural remission, timing of assessment, and general considerations when using intestinal ultrasound in inflammatory bowel disease.

CONCLUSIONS: Response criteria and time-points of response assessment varied between studies complicating direct comparison of parameter changes and their relation to treatment outcomes. To ensure a unified approach in routine care and clinical trials, we provide recommendations and definitions for key parameters for intestinal ultrasound response to incorporate into future prospective studies.

TidsskriftJournal of Crohn's & colitis
StatusE-pub ahead of print - 6 okt. 2021

Bibliografisk note

© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

ID: 68351111